← Leaderboards
Chiratidzo Ellen Ndhlovu
College Of Health Scis Univ Of Zimbabwe
$8,821,392
Attributed
$8,821,392
Total exposure
4
Grants
4
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $3.4M · FY2006–19$5M$3.8M$2.5M$1.3M$0
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
Funding mix
By agency
CDC$8,528,644 · 3
NIH$292,748 · 1
By mechanism
U2G$5,694,500 · 1
U01$2,834,144 · 2
R21$292,748 · 1
Top collaborators
No co-investigators on record.
Most similar at College Of Health Scis Univ Of Zimbabwe
Same institution · by research overlap
- James Gita Hakim$14,608,047
- Mufuta Tshimanga$11,340,001
- Peter R Mason$2,009,932
- Patience Kuona$904,461
- Justen Manasa$1,249,155
Others in their field
Top investigators on “Adolescent”
- Lawrence Corey · Fred Hutchinson Cancer Center$481,946,630
- Gregory H Reaman · National Childhood Cancer Foundation$264,737,004
- Barbara Driver · Westat, Inc.$232,205,725
- George R Seage · Abt Associates, Inc.$222,555,872
- Sharon A Nachman · Johns Hopkins University$213,337,729
- Kathryn Hirst · Caritas St. Elizabeth'S Medical Center$198,115,770
Research focus
AdolescentAdherenceAfrica South Of The SaharaAge GroupAdolescent And Young AdultAntiretroviral TherapyBaseBioinformaticsBloodCaringAids/Hiv ProblemClinicClinical CareCohortCommunitiesContinuity Of Patient CareCostCost EfficientCounselingDetectionDideoxy Chain Termination Dna SequencingDideoxynucleotideChildDrug Monitoring
Grant awards (16)
GH16-005, Zimbabwe, Implementing a sustainable adherence intervention, monitoring virologic suppression and drug resistance among HIV-infected adolescents receiving Antiretroviral treatment$1
U01 · FY2019 · GH · contact PI
GH16-005, Zimbabwe, Implementing a sustainable adherence intervention, monitoring virologic suppression and drug resistance among HIV-infected adolescents receiving Antiretroviral treatment$499,999
U01 · FY2018 · GH · contact PI
GH16-005, Zimbabwe, Implementing a sustainable adherence intervention, monitoring virologic suppression and drug resistance among HIV-infected adolescents receiving Antiretroviral treatment$500,000
U01 · FY2017 · GH · contact PI
Implementing objective measures of adherence and low cost genotyping to assess a community based intervention to strengthen virologic outcomes among youth failing ART$108,028
R21 · FY2017 · AI · contact PI
GH16-005, Zimbabwe, Implementing a sustainable adherence intervention, monitoring virologic suppression and drug resistance among HIV-infected adolescents receiving Antiretroviral treatment$500,000
U01 · FY2016 · GH · contact PI
Implementing objective measures of adherence and low cost genotyping to assess a community based intervention to strengthen virologic outcomes among youth failing ART$184,720
R21 · FY2016 · AI · contact PI
GH12-008: The CryptoART Study: Decreasing mortality associated with initiation of antiretro$829,328
U01 · FY2015 · GH · contact PI
The CryptoART Study: Decreasing mortality associated with initiation of antiretro$5,000
U01 · FY2014 · GH · contact PI
The CryptoART Study: Decreasing mortality associated with initiation of antiretro$499,816
U01 · FY2013 · GH · contact PI
Improving the Quality of HIV/AIDS Care in Zimbabwe under PEPFAR$550,000
U2G · FY2011 · PS · contact PI
Improving the Quality of HIV/AIDS Care in Zimbabwe under PEPFAR$3,412,500
U2G · FY2010 · PS · contact PI
Improving the Quality of HIV/AIDS Care in Zimbabwe under PEPFAR$350,000
U2G · FY2009 · PS · contact PI
Improving the Quality of HIV/AIDS Care in Zimbabwe under PEPFAR$350,000
U2G · FY2008 · PS · contact PI
Improving the Quality of HIV/AIDS Care in Zimbabwe under PEPFAR$332,000
U2G · FY2008 · PS · contact PI
Improving the Quality of HIV/AIDS Care in Zimbabwe under PEPFAR$350,000
U2G · FY2007 · PS · contact PI
Improving the Quality of HIV/AIDS Care in Zimbabwe under PEPFAR$350,000
U2G · FY2006 · PS · contact PI